How to increase the commercial potential of your research
pd_plus_squiz_1.png
About this event
- Why commercialise your research
- Identifying the commercial potential of your research
- Protecting your research assets
- The role of industry
- Sources of assistance and funding
- Case Studies
Meet your Presenter
Rob Crombie is currently the VIC/TAS State Lead for i4 Connect delivering the Federal Governments Accelerating Commercialisation programme through his role as Managing Director of Concept2Clinic Consulting, a specialist professional services company looking to turn smart innovation into commercial ventures.
Rob’s has had previous roles as CEO of VC backed QUE Oncology Incorporated as well as the founding CEO of ASX-listed Prescient Therapeutics, in-licensing early stage drug candidates from Universities including Yale and Emory University and building value by advancing these assets through company sponsored clinical trials.
Rob also played a key role as Head of Melbourne Operations at Arana Therapeutics taking the company from CSIRO spin-out through an IPO and merger to Arana’s final $318M upfront cash sale to US-based Cephalon Incorporated.
PD+ streams: Commercialisation of Research | Strategic
Event Information
- Date: This event was held on Friday 10 June 2022
- Location: Zoom
The University of Newcastle acknowledges the traditional custodians of the lands within our footprint areas: Awabakal, Darkinjung, Biripai, Worimi, Wonnarua, and Eora Nations. We also pay respect to the wisdom of our Elders past and present.